Classic Biotech & Exports (Delisted) share price
BSE: 531670
Classic Biotech & Exports Ltd. · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Oct 2000
Last traded ₹6.18 on 28 Dec 2007
Delisted on 1 Dec 2017.
Results for the quarter to Jun 2008
Standalone: the listed company alone, without its subsidiaries. ₹ crore.
- RevenueRevenue from operations. Money earned from selling the company's goods and services in the period. Revenue from operations in the glossary
- ₹0.17 Cr−44.4% on the quarter beforeChange on a year ago and on the quarter before. The change against the same quarter a year before: (this quarter's figure less that quarter's) divided by that quarter's, times 100. The change on the quarter before is the same sum against the quarter just before, taken as this quarter's results restate it where the company restated it: this quarter's year to date less this quarter. Left out where either figure is a loss, where the restatement covers two or more earlier quarters without saying which, or across a change of basis named under the table, on the lines it affects.
- Net profitNet profit. What is left of revenue and other income after every cost, interest and tax. Net profit in the glossary
- −₹0.11 Cr
- Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax. Net margin in the glossary
- −62.6%
From revenue to net profit, ₹ crore
- Revenue0.2
- Depreciation0.0
- One-off items0.0
- Profit before tax−0.1
- Net profit−0.1
Classic Biotech & Exports results by quarter
Standalone: the listed company alone, without its subsidiaries. Latest quarter to Jun 2008. Results for the quarter to Sep 2008 were due by 14 Nov 2008, 45 days after it ends. Every company's dates are on the results calendar.
Revenue and net profit by quarter, ₹ crore
- Revenue
- Net profit
- Loss
Peak revenue ₹0.31 Cr, quarter to Mar 2008; lowest ₹0.16 Cr, quarter to Sep 2007A loss in 4 of the 4 quarters shown
Operating and net margin by quarter, per cent
- Operating marginOperating margin. Operating profit before depreciation as a percentage of revenue: how much of each rupee of sales is left after running costs. Operating margin in the glossary
- Net margin
| ₹ crore | Sep 2007 | Dec 2007 | Mar 2008 | Jun 2008 |
|---|---|---|---|---|
| Revenue from operations | 0.16 | 0.24 | 0.31 | 0.17 |
| Operating expenses. What the business spent to run itself in the period, materials, staff and other costs, before depreciation, interest and tax. Operating expenses in the glossary | – | – | – | – |
| Materials and goods boughtCost of materials and goods. Raw materials used and goods bought for resale in the period, adjusted for the change in stock held. Cost of materials and goods in the glossary | 0.13 | 0.13 | 0.18 | 0.15 |
| Depreciation and amortisationDepreciation and amortisation. The part of the cost of plant, buildings and other long-lived assets charged against each year they are used. Depreciation and amortisation in the glossary | 0.07 | 0.09 | 0.07 | 0.03 |
| One-off itemsExceptional items. Gains or losses the company reports separately because they are not expected to recur, such as selling a business or writing down an asset. Exceptional items in the glossary | – | −0.12 | −0.06 | −0.02 |
| Profit before tax | −0.17 | −0.19 | −0.15 | −0.11 |
| Net profit | −0.17 | −0.19 | −0.15 | −0.11 |
| Net margin | −107.5% | −81.3% | −48.2% | −62.6% |
Earnings per share in rupees, restated for later splits and bonuses.
1 year at a glance
Standalone: the listed company alone, without its subsidiaries. ₹ crore, years to March.
Revenue, net profit and borrowings, ₹ crore
- Revenue
- Net profit
- Borrowings
- Loss
Operating and net margin, per cent
- Operating margin
- Net margin
Results for the year to Mar 2008
Standalone: the listed company alone, without its subsidiaries. ₹ crore.
From revenue to net profit
- Revenue0.9
- Depreciation−0.3
- One-off items−0.3
- Profit before tax−0.7
- Net profit−0.7
Profit and loss
Standalone, ₹ crore, years to March. The last column is the twelve months to Jun 2008, the latest four quarters added.
| ₹ crore | Mar 2008 | Jun 2008Twelve months |
|---|---|---|
| Revenue from operations | 0.90 | 0.88 |
| – | – | |
| Materials and goods bought | 0.57 | 0.59 |
| Depreciation and amortisation | 0.27 | 0.26 |
| One-off items | −0.32 | – |
| Profit before tax | −0.66 | −0.62 |
| Net profit | −0.66 | −0.62 |
| Net margin | −73.4% | −70.7% |
Operating expenses, operating profit before depreciation and operating profit after depreciation are left blank for the year to Mar 2008: the statement does not state its finance costs, which operating profit is worked out from, so operating profit is not given.
Recent sessions
The 10 trading days to 28 Dec 2007, as traded on BSE.
| Date | Open | High | Low | Close | Average price | Volume |
|---|---|---|---|---|---|---|
| 28 Dec 2007 | 6.14 | 6.18 | 6.14 | 6.18 | 6.17 | 30,144 |
| 27 Dec 2007 | 5.89 | 5.89 | 5.89 | 5.89 | 5.89 | 16,425 |
| 26 Dec 2007 | 5.60 | 5.61 | 5.60 | 5.61 | 5.61 | 21,254 |
| 24 Dec 2007 | 5.35 | 5.35 | 5.35 | 5.35 | 5.35 | 19,340 |
| 20 Dec 2007 | 5.10 | 5.10 | 5.10 | 5.10 | 5.10 | 13,299 |
| 19 Dec 2007 | 4.86 | 4.86 | 4.86 | 4.86 | 4.86 | 8,781 |
| 18 Dec 2007 | 4.63 | 4.63 | 4.63 | 4.63 | 4.63 | 19,936 |
| 17 Dec 2007 | 4.41 | 4.41 | 4.41 | 4.41 | 4.41 | 29,590 |
| 14 Dec 2007 | 4.20 | 4.20 | 4.20 | 4.20 | 4.20 | 12,256 |
| 13 Dec 2007 | 4.00 | 4.00 | 4.00 | 4.00 | 4.00 | 32,220 |
Prices in ₹ per share as traded, not adjusted.
Company details
- BSE code
- 531670
- ISIN
- INE038C01018
- Website
- www.classicbiotech.com
- CIN
- L51215AP1994PLC017673
- Corporate identity number, the registrar of companies' code for it
- Incorporated
- 1994
- Registered office
- 133 - B Vengal Rao Nagar, Hyderabad 500038, Telangana
- Share registrar
- CIL Securities Ltd
- Keeps the register of shareholders and handles transfers and dividend payments